{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

A disease and management insight survey to understand prevalence and treatment practices in management of melasma among dermatologists in India

Survey Questionnaire Form
Doctor’s details
@if(isset(session()->get('doctor')['vCentralCode']))
@else
@endif {{--
--}}

Questionnaire

  1. What are the common hyperpigmentary conditions of face do you see in your clinical practice? (More than 1 options can be selected) *

  2. Considering patients with hyperpigmentation of face you see in your clinic as 100%, what are the % of patients you see for below hyperpigmentary conditions? *
    3. Melasma
    %
    Sun burn/tanning
    %
    Periorbital hyperpigmentation
    %
    Post-inflammatory hyperpigmentation
    %

    %
  3. In Melasma, what % of patients present with below clinical presentations? *
    4. Centrofacial
    %
    Malar
    %
    Mandibular
    %
    Extrafacial
    %
  4. Who is more commonly affected by Melasma (Ex. Skintype, age, gender etc.) *

  5. In what percentage of your patients there is a family history of melasma? *

  6. What are the common treatment options you suggest to the patient with melasma *

  7. Which type of sunscreen do you prefer in patients with melasma? *

  8. What are the properties you look for while choosing a sunscreen in your patients with melasma? *

  9. Do you prefer to use triple combination in your melasma patients? *

  10. How early do you see results with triple combination in your patients? *

  11. Which anti-oxidant do you prefer to you in patients with melasma? *

  12. Do you use tranexamic acid in your patients with melasma? If yes, Which route of administration and dose, do you prefer for tranexamic acid?
    13. Topical : Dosage and duration
    Oral: Dosage and duration
    Intralesional: Dosage and duration
  13. For how long do you recommend your patients to consume super-oxide dismutase *

  14. In what percentage of your patients with melasma do you see relapse? *

{{-- Backend Script --}} {{-- Backend Script ends --}}